Mr. Suman Maarisetty

Suman Maarisetty has a proven performance credentials over the past 15 years in the pharmaceutical industry. He is spearheading OrciMed Life Sciences to its next growth orbit as the Chief Executive Officer of the company. Prior to joining OrciMed Life Sciences, Suman has co-founded and sculpted Vigi Medsafe, a niche pharmacovigilance service provider in the health care sector. His quest for perfection and relentless focus has set the operations on its track within one year of its inception. He has been instrumental in setting up the entire end-to-end capability for service delivery, operations and lead the team of highly accomplished scientific talent to deliver various complex project deliverables with high quality. Vigi MedSafe was conceived in 2013 with humble beginning and the company exponentially transitioned to industry leading clinical research organization through 2014 to 2019 attaining global platform with unparalleled customer partnerships and thoughtful proficiency in influential healthcare delivery and was acquired by PPD Inc in 2019. Suman, early in his career, has worked in regulatory agency-Medicines and Healthcare products Regulatory Agency (MHRA) and ingeniously utilized the period of his career spanning across vital and enriching engagements with global pharmaceutical organizations like PPD (a part of Thermo Fisher Scientific), Novartis and Eli Lilly. His strong scientific skills and passion for business gives him an edge with complete end-to-end visibility, right from customer audit due diligence to customer engagement for quality deliverables. Suman’s management strategies, revolutionary vision and unique style of engagement with multilevel stakeholders makes him a favourite leader among his customers and employees.